FotiosKoumpourasMD

Director Yale Lupus Program

Dr. Koumpouras is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Yale-New Haven Medical CenterFellowship, Rheumatology, 2004 - 2007
Stony Brook Medicine/University HospitalResidency, Internal Medicine, 2000 - 2003
St. George's University School of MedicineClass of 2000

CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012-2013
Fellow (FACR) American College of Rheumatology

PubMed

Outcomes following total shoulder arthroplasty in patients with systemic lupus erythematosus.
Andrew Salib, Joshua G Sanchez, Lenique Huggins, Anthony E Seddio, Meera M Dhodapkar
Journal of Shoulder and Elbow Surgery. 2024-08-16
A dual-acting DNASE1/DNASE1L3 biologic prevents autoimmunity and death in genetic and induced lupus models.
Paul R Stabach, Dominique Sims, Eduardo Gomez-Bañuelos, Sandra Zehentmeier, Kris Dammen-Brower
JCI Insight. 2024-06-18
Chimeric antigen receptors: "CARs" in the fast lane for rheumatology.
Nathan M Johnson, Fotios Koumpouras
Current Opinion in Rheumatology. 2024-05-01

Journal Articles

Chimeric antigen receptors: “CARs” in the fast lane for rheumatology
Nathan Johnson and Fotios Koumpouras, Current Opinion in Rheumatology, 5/2024

'The future is bright.' Yale doctor helps to advance the fight against lupusMarch 7th, 2024
New Cell Therapy Program to Offer Hope for Patients with Severe LupusJune 14th, 2023
Two for OneJune 17th, 2024
Join now to see all